PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3430

  1. 284 Posts.
    lightbulb Created with Sketch. 46
    Also having the exclusive agreement with Bene for supply once we get the nod has alot of weight its all starting to come together nicely Go Paradigm.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.